Serous otitis media in children: implication of Alloiococcus otitidis

Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
Isabel de Miguel Martínez, Angel Ramos Macias

Abstract

Otitis media with effusion (OME) has long been considered to be a noninfective disease resulting from a eustachian tube dysfunction. However, several microbiological techniques have shown bacteria in the middle ear fluids from patients with OME. Alloiococcus otitidis has been detected in the middle ear fluid from patients with OME. The exact role of this infectious agent in the pathogenesis of OME has yet to be elucidated. A prospective clinical trial. A tertiary university-based referral center. The inclusion criteria included 110 patients aged between 1 and 12 years. The control group included samples obtained from 30 healthy children undergoing a cochlear implantation. The second group included 40 middle ear effusions (MEEs) that were collected from 40 pediatric OME patients during the placement of the ventilation tube. As for the third group, they were 40 children with acute otitis media. The bacterial analysis of the MEE was performed by means of microbiological culture-specific techniques. Positive cultures for A. otitidis as analyzed by bacteriological analysis of samples from the middle ear mucosa and MEE. Bacteria were present in the culture of 72.5% (29) of the patients with OME. Alloiococcus otitidis was the most fre...Continue Reading

References

Jan 1, 1992·International Journal of Systematic Bacteriology·M Aguirre, M D Collins
Nov 1, 1995·Journal of Clinical Microbiology·G S BosleyD F Talkington
Dec 1, 1996·Antimicrobial Agents and Chemotherapy·G FunkeA von Graevenitz
Apr 7, 1999·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C Gómez-HernandoM Baquero
Oct 26, 1999·The Pediatric Infectious Disease Journal·P H HendolinJ Ylikoski
Jan 5, 2000·Journal of Clinical Microbiology·P H HendolinJ Ylikoski
Oct 29, 2000·The Annals of Otology, Rhinology, and Laryngology·J TarkkanenP S Mattila
Nov 4, 2000·Journal of Clinical Microbiology·P H HendolinJ Ylikoski
Apr 20, 2001·Annals of Medicine·A P FraiseA J Beswick
Oct 5, 2002·International Journal of Pediatric Otorhinolaryngology·Kimmo LeskinenJussi Jero
Dec 23, 2003·International Journal of Pediatric Otorhinolaryngology·Kimmo LeskinenJussi Jero
May 13, 2004·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Richard M RosenfeldUNKNOWN American Academy of Otolaryngology--Head and Neck Surgery
May 12, 2005·International Journal of Pediatric Otorhinolaryngology·David M PoetkerJoseph E Kerschner
Nov 29, 2005·International Journal of Pediatric Otorhinolaryngology·Atsushi HarimayaTetsuo Himi
Mar 7, 2006·Journal of Clinical Microbiology·Atsushi HarimayaTetsuo Himi
Nov 11, 2006·FEMS Immunology and Medical Microbiology·Atsushi HarimayaNobuhiro Fujii

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.